Metabolic Signature-Based Subtypes May Pave Novel Ways for Low-Grade Glioma Prognosis and Therapy
Metabolic signatures are frequently observed in cancer and are starting to be recognized as important regulators for tumor progression and therapy. Because metabolism genes are involved in tumor initiation and progression, little is known about the metabolic genomic profiles in low-grade glioma (LGG...
Guardado en:
Autores principales: | Ganglei Li, Zhanxiong Wu, Jun Gu, Yu Zhu, Tiesong Zhang, Feng Wang, Kaiyuan Huang, Chenjie Gu, Kangli Xu, Renya Zhan, Jian Shen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4081c3bc4a9e4bcca4056144667cfe62 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes
por: Zhengang Hu, et al.
Publicado: (2021) -
Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma
por: Junsheng Zhao, et al.
Publicado: (2021) -
Transcription Factor Signatures May Predict the Prognosis and Status of the Immune Microenvironment of Primary Lower-Grade Gliomas
por: Liu P, et al.
Publicado: (2021) -
Identification and validation of an autophagy-related signature for predicting survival in lower-grade glioma
por: Shaobin Feng, et al.
Publicado: (2021) -
Prediction of Survival Outcome in Lower-Grade Glioma Using a Prognostic Signature with 33 Immune-Related Gene Pairs
por: Chen S, et al.
Publicado: (2021)